D-72
Today is  2024. 09. 17.

Program
Program at a Glance Scientific Program Invited Speakers

07:00 - 08:00 Breakfast Symposium 1 [ Daiichi-Sankyo ]
07:00 - 08:00
Breakfast Symposium 1 [ Daiichi-Sankyo ]

Chairperson

TBD
07:00 - 07:30

TBD
07:30 - 08:00

TBD
08:00 - 08:30

Break
08:30 - 10:10 Symposium 7
What SGLT2 Inhibitors have Changed in Our Field - Multidisciplinary Perspectives
08:30 - 10:10
Symposium 7
What SGLT2 Inhibitors have Changed in Our Field - Multidisciplinary Perspectives

Organizer : Jong-Chan Youn (The Catholic University of Korea, Korea)

  • In this multidisciplinary session, we begin with an exploration of the known and unknown mechanisms of SGLT2 inhibitors, providing a foundational understanding of their function and impact.
  • Next, we will hear from leading experts in various fields: diabetologists will discuss the transformative effects of SGLT2 inhibitors on diabetes management, cardiologists will share insights into cardiovascular benefits, and nephrologists will examine the implications for kidney health.

Chairpersons

Hye Young Lee (Seoul National University, Korea)
Jae Hyuk Lee (Myongji Hospital, Korea)
08:30 - 08:50

The Known and Unknonw Mechanisms of SGLT2 Inhibitors

Yong-Ho Lee (Yonsei University, Korea)
08:50 - 09:10

What SGLT2 Inhibitors have Changed in Our Field - Diabetologist's Perspectives

Eun Young Lee (The Catholic University of Korea, Korea)
09:10 - 09:30

What SGLT2 Inhibitors have Changed in Our Field - Cardiologist's Perspectives

Dong-Hyuk Cho (Korea University, Korea)
09:30 - 09:50

What SGLT2 Inhibitors have Changed in Our Field - Nephrologist's Perspectives

Hyung Deok Kim (The Catholic University of Korea, Korea)
09:50 - 10:10

Panel Discussion

Jinhwa Kim (Chosun University, Korea), Yoo Ran Ahn (The Catholic University of Korea, Korea)

Han Bi Lee (The Catholic University of Korea, Korea), Ji Yeon Hong (Hallym University, Korea)
10:10 - 10:30

Coffee Break
10:30 - 11:10 Plenary Lecture 3
10:30 - 11:10
Plenary Lecture 3

Chairpersons

Sang Hong Baek (The Catholic University of Korea, Korea)
10:30 - 11:10

The Role of SGLT2i in Integrative Management of Cardio-Renal-Metabolic Diseases

David Cherney (University Health Network, Canada)
11:10 - 12:50 Symposium 9
Obesity and Cardiovascular Disease
11:10 - 12:50
Symposium 9
Obesity and Cardiovascular Disease

Organizer : Jong-Chan Youn (The Catholic University of Korea, Korea)

  • In this session, we will explore the intricate link between these two critical health conditions. Our program begins with an overview of obesity, its definition, and clinical implications, setting the stage for understanding its impact on cardiovascular health. We'll then delve into the intriguing obesity paradox in cardiovascular disease, followed by insights into the role of bariatric surgery for obese patients with cardiovascular conditions. Finally, we will discuss the latest advancements in pharmacotherapy for these patients.

Chairpersons

Hyuk Sang Kwon (The Catholic University of Korea, Korea)
Sang Hak Lee (Yonsei University, Korea)
11:10 - 11:30

Obesity: Definition and Clinical Implications

Sang Woo Oh (Dongguk University, Korea)
11:30 - 11:50

Obesity Paradox in Cardiovascular Disease

Da Rae Kim (Sungkyunkwan University, Korea)
11:50 - 12:10

Bariatric Surgery for Obese Patients with Cardiovascular Disease

Moon Won Yoo (University of Ulsan, Korea)
12:10 - 12:30

Novel Pharmacotherapy for Obese Patients with Cardiovascular Disease

Soo Lim (Seoul National University, Korea)
12:30 - 12:50

Panel Discussion

Dae Young Cheon (Hallym University, Korea), Joon Ho Hyun (University of Ulsan, Korea)

Yeoree Yang (The Catholic University of Korea, Korea), Mihae Seo (Soonchunhyang University, Korea)
12:50 - 13:50 Luncheon Symposium 3 [ Daewoong Bio Incorporated ]
12:50 - 13:50
Luncheon Symposium 3 [ Daewoong Bio Incorporated ]

Chairperson

Sang Hyun Lim (The Catholic University of Korea, Korea)
12:50 - 13:50

[ICOSA] Clinical Value of EPA

Dae Young Cheon (Hallym University, Korea)
13:50 - 14:30 Plenary Lecture 4
13:50 - 14:30
Plenary Lecture 4
  • The carotid intima‑media thickness test (CIMT) is a measure used to diagnose the extent of carotid atherosclerotic vascular disease. The test measures the thickness of the inner two layers of the carotid artery—the intima and media—and alerts physicians to any thickening when patients are still asymptomatic. CIMT shows good correlation with the extent of one person’s atherosclerotic disease and predicts future cardiovascular events. CIMT is non-invasive and could be easily performed in the clinic for the prediction of atherosclerotic disease in our patients. In this plenary lecture, Prof. Yong-Jae Kim from The Catholic University of Korea will tell us about the role of CIMT in the risk stratification of cardiovascular risk.

Chairpersons
13:50 - 14:30

Black and White: The Evolving Role of Carotid Intima-Media Thickness in Risk Stratification

Yong-Jae Kim (The Catholic University of Korea, Korea)
14:30 - 14:50

Coffee Break
14:50 - 16:30 Symposium 11
Lifestyle Modification for Prevention of Cardiovascular Disease
13:50 - 15:00
Symposium 11
Lifestyle Modification for Prevention of Cardiovascular Disease

Chairpersons
14:50 - 15:10
15:10 - 15:30
15:30 - 15:50
15:50 - 16:10
16:10 - 16:30

Panel Discussion
16:30 - 16:50 Closing Ceremony
16:30 - 16:50
Closing Ceremony
07:00 - 08:00 Breakfast Symposium 2 [TBD]
07:00 - 08:00
Breakfast Symposium 2 [TBD]

Chairperson
07:00 - 07:30

TBD
07:30 - 08:00

TBD
08:00 - 08:30

Break
08:30 - 10:10 Symposium 8
Non-Traditional Risk Factors of Cardiovascular Disease
08:30 - 10:10
Symposium 8
Non-Traditional Risk Factors of Cardiovascular Disease

Chairpersons
08:30 - 08:50

Cardiovascular Risk in Breast Cancer Survivorship: Latest Findings

Yong-Moon Mark Park (University of Arkansas for Medical Sciences, USA)
08:50 - 09:10
09:10 - 09:30

Synergistic Effect of Lipoprotein (a) and C-reactive Protein on Prognosis of Familial Hypercholesterolemia

Hayato Tada (Kanazawa University, Japan)
09:30 - 09:50
09:50 - 10:10

Panel Discussion
10:10 - 10:30

Coffee Break
10:30 - 11:10 Plenary Lecture 3
10:30 - 11:10
Plenary Lecture 3

Chairpersons

Sang Hong Baek (The Catholic University of Korea, Korea)
10:30 - 11:10

The Role of SGLT2i in Integrative Management of Cardio-Renal-Metabolic Diseases

David Cherney (University Health Network, Canada)
11:10 - 12:50 Symposium 10
Regional, Social Disparities in CV and Metabolic Health Outcomes
11:10 - 12:50
Symposium 10
Regional, Social Disparities in CV and Metabolic Health Outcomes

Organizer : Seung-Hyun Ko (The Catholic University of Korea, Korea)

  • Cardiometabolic diseases are major health issues all around the world, especially in Korea, and standard guidelines for the average person continue to evolve. However, health disparities in certain groups still exist, and efforts to resolve them are on-going. This session explores the uneven distribution of these conditions across different social and regional factors, examining how factors such as socioeconomic status, urbanization, and access to healthcare influence these disparities. By understanding the underlying causes and regional differences, we aim to develop targeted interventions and policies to alleviate these disparities, improve public health outcomes, and ensure equitable healthcare access for all Koreans.

Chairpersons
11:10 - 11:30

Cardiovascular and Renal Health Outcomes in Single-Person Households

Seung-Hwan Lee (The Catholic University of Korea, Korea)
11:30 - 11:50

Regional Disparities in Prehospital Delay of Acute Ischemic Stroke

Keun-Hwa Jung (Seoul National University, Korea)
11:50 - 12:10

Disparities in Mortality and Cardiovascular Events by Income and Blood Pressure Levels Among Patients with Hypertension in South Korea

Ki-Chul Sung (Sungkyunkwan University, Korea)
12:10 - 12:30
12:30 - 12:50

Panel Discussion
12:50 - 13:30 Luncheon Symposium 4 [Celltrion & Boryung ]
12:50 - 13:50
Luncheon Symposium 4 [Celltrion & Boryung ]

Chairperson

TBD
12:50 - 13:10

TBD
13:10 - 13:30

TBD

Seung-Hwan Lee (The Catholic University of Korea, Korea)
13:50 - 14:30 Plenary Lecture 4
13:50 - 14:30
Plenary Lecture 4
  • The carotid intima‑media thickness test (CIMT) is a measure used to diagnose the extent of carotid atherosclerotic vascular disease. The test measures the thickness of the inner two layers of the carotid artery—the intima and media—and alerts physicians to any thickening when patients are still asymptomatic. CIMT shows good correlation with the extent of one person’s atherosclerotic disease and predicts future cardiovascular events. CIMT is non-invasive and could be easily performed in the clinic for the prediction of atherosclerotic disease in our patients. In this plenary lecture, Prof. Yong-Jae Kim from The Catholic University of Korea will tell us about the role of CIMT in the risk stratification of cardiovascular risk.

Chairpersons
13:50 - 14:30

Black and White: The Evolving Role of Carotid Intima-Media Thickness in Risk Stratification

Yong-Jae Kim (The Catholic University of Korea, Korea)
14:30 - 14:50

Coffee Break
14:50 - 16:30 Symposium 12
Digital Healthcare
14:50 - 16:30
Symposium 12

Chairpersons
14:50 - 15:10

TBD

Seonghoon Choi (Hallym University, Korea)
15:10 - 15:30
15:30 - 15:50
15:50 - 16:10
16:10 - 16:30

Panel Discussion
16:30 - 16:50 Closing Ceremony
16:30 - 16:50
Closing Ceremony